TCF7L2 and Impaired glucose tolerance: The TCF7L2 rs7903146T genotype did not predict development of clinically diagnosable hyperglycemia (fasting blood glucose ≥ 126 mg/dl) or impaired glucose tolerance (2-h OGTT blood glucose ≥ 140 mg/dl) following bed rest.